E-Msion, Inc.
Corvallis, OR · Medtech
ExD electron-fragmentation cell for mass spectrometers that fragments biological macromolecules with exceptional sequence coverage and preservation of post-translational modifications
e-msion.com →- Grants
- $9.8M
- 14 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 3
- 1 granted · 2 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2017201820192020202120222023
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase II · Practical Mass Spectrometer Upgrade for Identifying Fragile Protein Modifications by ECD | $746,325 | |
| Federal grant | Department of Health and Human Services · Phase II · Practical Mass Spectrometry Upgrade for Identifying Fragile Protein Modifications by ECD | $1,751,788 | |
| Federal grant | Department of Health and Human Services · Phase I · Enabling electron-induced fragmentation in tandem mass spectrometry | $225,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Practical Mass Spectrometer Upgrade for Identifying Fragile Protein Modifications by ECD | $746,325 | |
| Federal grant | Department of Health and Human Services · Phase II · Enabling electron-induced fragmentation in tandem mass spectrometry | $1,492,650 | |
| Federal grant | Department of Health and Human Services · Phase II · Practical Mass Spectrometry Upgrade for Identifying Fragile Protein Modifications by ECD | $259,138 | |
| Federal grant | Department of Health and Human Services · Phase II · Enabling electron-induced fragmentation in tandem mass spectrometry | $746,325 | |
| Federal grant | Department of Health and Human Services · Phase I · Inert Gas Modulation of Electron-Based Fragmentation for Proteomics | $223,899 | |
| Federal grant | Department of Health and Human Services · Phase II · Dual Electron-Based Fragmentation with Ion Mobility to Advance Native Top-Down Proteomics | $1,492,650 | |
| Federal grant | Department of Health and Human Services · Phase I · Real time optimization of electron-based fragmentation for middle and top-down proteomics in mass spectrometry | $212,830 | |
| Federal grant | Department of Health and Human Services · Phase I · Advancing native top-down protein analysis with hybrid SID/ECD technology | $252,070 | |
| Federal grant | Department of Health and Human Services · Phase II · Dual Electron-Based Fragmentation with Ion Mobility to Advance Native Top-Down Proteomics | $746,325 | |
| Federal grant | Department of Health and Human Services · Phase II · An adaptive compute solution for characterizing macromolecular complexes by mass spectrometry with electron-based fragmentation | $865,373 | |
| Federal grant | Department of Health and Human Services · Phase II · An adaptive compute solution for characterizing macromolecular complexes by mass spectrometry with electron-based fragmentation | $1 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1870 | FISTULA SOLUTION CORPORATION | — | — |
| 1871 | LifeWave, Inc. | — | $618K |
| 1872 | Narnar, LLC | — | — |
| 1873 | E-Msion, Inc. | — | — |
| 1874 | Quantum NanoStim LLC | — | — |
| 1875 | REFLODX, INC. | — | — |
| 1876 | Smart Skin Technologies Inc. | — | $85K |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Reflectron-electromagnetostatic Cell For Ecd Fragmentation In Mass Spectrometersgranted
- Radiofrequency-free Electromagnetostatic Cell To Improve Electron-based Fragmentation Of Biological Moleculesapplication
- Reflectron-electromagnetostatic Cell For Ecd Fragmentation In Mass Spectrometersapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.